Literature DB >> 19912220

Serum granulysin as a possible biomarker of natural killer cell neoplasms.

Masayuki Nagasawa, Kazuyuki Ogawa, Kinya Nagata, Norio Shimizu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19912220     DOI: 10.1111/j.1365-2141.2009.07999.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms.

Authors:  Nodoka Sekiguchi; Naoko Asano; Toshiro Ito; Kayoko Momose; Masanobu Momose; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2012-08-14       Impact factor: 2.490

2.  Epstein-Barr-Virus-Positive B-Cell Lymphoma of Recipient Origin Despite of the Elimination of Clonally EBV-Infected T Cells by Allogeneic Stem Cell Transplantation in a Patient with Chronic Active EBV Infection.

Authors:  Masayuki Nagasawa
Journal:  Case Rep Transplant       Date:  2012-06-13

3.  Granulysin as a novel factor for the prognosis of the clinical course of chickenpox.

Authors:  R Baljic; R Gojak; H Konjo; M Hukic
Journal:  Epidemiol Infect       Date:  2018-04-10       Impact factor: 4.434

4.  Early Response of CD8+ T Cells in COVID-19 Patients.

Authors:  Deni Ramljak; Martina Vukoja; Marina Curlin; Katarina Vukojevic; Maja Barbaric; Una Glamoclija; Bejana Purisevic; Olivera Peric; Violeta Soljic
Journal:  J Pers Med       Date:  2021-12-03

5.  Identification of Diagnostic Signatures and Immune Cell Infiltration Characteristics in Rheumatoid Arthritis by Integrating Bioinformatic Analysis and Machine-Learning Strategies.

Authors:  Rongguo Yu; Jiayu Zhang; Youguang Zhuo; Xu Hong; Jie Ye; Susu Tang; Yiyuan Zhang
Journal:  Front Immunol       Date:  2021-10-06       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.